Myriad Genetics, Inc. (MYGN)
4.38
+0.09
(+2.10%)
USD |
NASDAQ |
Feb 23, 16:00
5.18
+0.80
(+18.26%)
Pre-Market: 09:12
Myriad Genetics Shareholders Equity (Quarterly) : 372.80M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ICU Medical, Inc. | 2.124B |
| Intuitive Surgical, Inc. | 17.82B |
| Insulet Corp. | 1.515B |
| West Pharmaceutical Services, Inc. | 3.176B |
| Celldex Therapeutics, Inc. | 598.36M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 728.10M |
| Total Liabilities (Quarterly) | 355.30M |
| Debt to Equity Ratio | 0.5695 |
| Current Ratio | 2.330 |
| Net Debt Paydown Yield | -2.05% |